Spona J - Search Results

1

Natural killer cell activities of patients with breast cancer against different target cells.

Hamilton G, Reiner A, Teleky B, Roth E, Kolb R, Spona J, Jakesz R. Hamilton G, et al. Among authors: spona j. J Cancer Res Clin Oncol. 1988;114(2):191-6. doi: 10.1007/BF00417836. J Cancer Res Clin Oncol. 1988. PMID: 3350852

2

Prognostic significance of steroid hormone receptors and histopathological characterization of human breast cancer.

Reiner A, Kolb R, Reiner G, Jakesz R, Schemper M, Spona J. Reiner A, et al. Among authors: spona j. J Cancer Res Clin Oncol. 1987;113(3):285-90. doi: 10.1007/BF00396387. J Cancer Res Clin Oncol. 1987. PMID: 3584218

3

Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis.

Reiner A, Reiner G, Spona J, Schemper M, Holzner JH. Reiner A, et al. Among authors: spona j. Cancer. 1988 Mar 15;61(6):1149-54. doi: 10.1002/1097-0142(19880315)61:6<1149::aid-cncr2820610615>3.0.co;2-z. Cancer. 1988. PMID: 2830006

4

Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.

Reiner A, Neumeister B, Spona J, Reiner G, Schemper M, Jakesz R. Reiner A, et al. Among authors: spona j. Cancer Res. 1990 Nov 1;50(21):7057-61. Cancer Res. 1990. PMID: 2208173

5

Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer.

Reiner A, Reiner G, Spona J, Teleky B, Kolb R, Holzner JH. Reiner A, et al. Among authors: spona j. Am J Clin Pathol. 1987 Oct;88(4):399-404. doi: 10.1093/ajcp/88.4.399. Am J Clin Pathol. 1987. PMID: 3661495

6

The human tumour cloning assay in the management of breast cancer patients.

Dittrich C, Jakesz R, Wrba F, Havelec L, Haas O, Spona J, Holzner H, Kolb R, Moser K. Dittrich C, et al. Among authors: spona j. Br J Cancer. 1985 Aug;52(2):197-203. doi: 10.1038/bjc.1985.178. Br J Cancer. 1985. PMID: 4027163 Free PMC article.

7

HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.

Stühlinger M, Rosen AC, Dobianer K, Hruza C, Helmer H, Kein M, Koukal T, Reiner A, Klein M, Spona J. Stühlinger M, et al. Among authors: spona j. Oncology. 1995 Sep-Oct;52(5):397-9. doi: 10.1159/000227496. Oncology. 1995. PMID: 7637958

8

Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.

Jakesz R, Reiner G, Schemper M, Reiner A, Blijham G, Rainer H, Dittrich D, Spona J, Schutte B, Reynders M, et al. Jakesz R, et al. Among authors: spona j. Recent Results Cancer Res. 1989;115:180-5. doi: 10.1007/978-3-642-83337-3_26. Recent Results Cancer Res. 1989. PMID: 2696031 Clinical Trial. No abstract available.

9

Clinical and experimental aspects of hormone receptors in breast carcinoma patients.

Spona J, Kolb R, Reiner G, Jakesz R, Moser K, Rainer H. Spona J, et al. Cancer Detect Prev. 1983;6(1-2):227-34. Cancer Detect Prev. 1983. PMID: 6883382

10

[Tumor histology and steroid receptors in breast carcinoma].

Jakesz R, Reiner A, Bieglmaier C, Reiner G, Krisch K, Kolb R, Spona J, Schemper M. Jakesz R, et al. Among authors: spona j. Onkologie. 1981 Apr;4(2):73-8. doi: 10.1159/000214882. Onkologie. 1981. PMID: 7022285 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters